BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will participate in the RBC Capital Markets Global Healthcare Conference on May 20, 2025, with a fireside chat at 10 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at http://ir.beigene.com/, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available ...

FoodChain ID, a provider of technology and services for the food industry, announces FoodChain ID Mentor, a groundbreaking AI innovation that empowers product development teams to deliver products with greater speed and accuracy by turning disconnected sources of knowledge into trusted guidance. FoodChain ID Mentor analyzes current-state formulations and dynamically applies guidance, providing real-time insights and warnings that accelerate time to market and reduce costly maintenance and rewor...

Minerva Biotechnologies published “Effective CAR T cell targeting of a MUC1 cleavage product” in the Journal for ImmunoTherapy of Cancer https://jitc.bmj.com/content/13/5/e010577. Novel target, MUC1*, is a cancer-specific growth factor receptor that is expressed on the surface of 75% of solid tumors. In this study, we compared the efficacy, persistence and antigen sensitivity of three MUC1* CARs, all directed to the tumor by the same antibody fragment, but bearing different co-stimulatory dom...

Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Tosoh Corporation, a major player in the global chemical industry, chose Kinaxis to streamline operations and support continued business growth. In an industry known for frequent disruptions, Tosoh needed a resilient, agile solution to enable the company to respond faster to market shifts and maintain operational continuity in a highly regulated and fast-evolving sector. As one of the largest ch...